Imagining an immune-driven future
The immune system is nature’s most finely-tuned diagnostic, so how will we use it to thwart disease and promote health?
Chad Robins
Chad Robins is the co-founder and CEO of Adaptive Biotechnologies, a commercial-stage biotech company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease. Prior to co-founding Adaptive, Chad held numerous executive-level positions in medical technology, investment and real estate companies. Chad holds an MBA from The Wharton School at the University of Pennsylvania and a BS in Managerial Economics from Cornell University.